These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 17932131)
1. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Kavsak PA; Ko DT; Newman AM; Palomaki GE; Lustig V; MacRae AR; Jaffe AS Clin Chem; 2007 Dec; 53(12):2112-8. PubMed ID: 17932131 [TBL] [Abstract][Full Text] [Related]
2. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908 [TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide. Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706 [TBL] [Abstract][Full Text] [Related]
5. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657 [TBL] [Abstract][Full Text] [Related]
6. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery. Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704 [TBL] [Abstract][Full Text] [Related]
7. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months]. Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399 [TBL] [Abstract][Full Text] [Related]
8. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay. Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790 [TBL] [Abstract][Full Text] [Related]
9. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure. Stanciu AE; Stanciu MM; Vatasescu RG Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475 [TBL] [Abstract][Full Text] [Related]
10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
11. Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes. Zelniker TA; Jarolim P; Scirica BM; Braunwald E; Park JG; Das S; Sabatine MS; Morrow DA J Am Heart Assoc; 2019 May; 8(9):e011444. PubMed ID: 31020897 [TBL] [Abstract][Full Text] [Related]
12. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study. Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923 [TBL] [Abstract][Full Text] [Related]
13. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? Kavsak PA; Newman AM; Ko DT; Palomaki GE; Lustig V; MacRae AR; Jaffe AS Clin Chem; 2008 Apr; 54(4):747-51. PubMed ID: 18375487 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease. Tuñón J; Blanco-Colio L; Cristóbal C; Tarín N; Higueras J; Huelmos A; Alonso J; Egido J; Asensio D; Lorenzo Ó; Mahíllo-Fernández I; Rodríguez-Artalejo F; Farré J; Martín-Ventura JL; López-Bescós L Am J Cardiol; 2014 Feb; 113(3):434-40. PubMed ID: 24295549 [TBL] [Abstract][Full Text] [Related]
15. Natriuretic and Inflammatory Biomarkers as Risk Predictors of Heart Failure in Middle-Aged Men From the General Population: A 21-Year Follow-Up. Ergatoudes C; Thunström E; Hansson PO; Morales D; Mandalenakis Z; Rosengren A; Zhong Y; Caidahl K; Fu M J Card Fail; 2018 Sep; 24(9):594-600. PubMed ID: 30048772 [TBL] [Abstract][Full Text] [Related]
16. [Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]. Higueras J; Martín-Ventura JL; Blanco-Colio L; Cristóbal C; Tarín N; Huelmos A; Alonso J; Pello A; Aceña Á; Carda R; Lorenzo Ó; Mahíllo-Fernández I; Asensio D; Almeida P; Rodríguez-Artalejo F; Farré J; López Bescós L; Egido J; Tuñón J Clin Investig Arterioscler; 2015; 27(2):57-63. PubMed ID: 25127747 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Dhillon OS; Khan SQ; Narayan HK; Ng KH; Mohammed N; Quinn PA; Squire IB; Davies JE; Ng LL Clin Sci (Lond); 2009 Nov; 118(4):249-57. PubMed ID: 19583569 [TBL] [Abstract][Full Text] [Related]
18. Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial. Sharma A; Vaduganathan M; Ferreira JP; Liu Y; Bakris GL; Cannon CP; White WB; Zannad F J Am Heart Assoc; 2020 Jan; 9(1):e012797. PubMed ID: 31902327 [TBL] [Abstract][Full Text] [Related]
19. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors. Suzuki S; Sugiyama S Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934 [TBL] [Abstract][Full Text] [Related]
20. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]